Adverse outcomes of proton pump inhibitors in patients with chronic kidney disease: The CKD-REIN cohort study.

Sophie LiabeufOriane LambertMarie MetzgerAghiles HamrounMaurice LavilleSolène M LavilleLuc FrimatRoberto Pecoits-FilhoDenis FouqueZiad A MassyChristian JacquelinetBénédicte Stengelnull null

Published in: British journal of clinical pharmacology (2021)

Long-term PPI prescription was common in CKD patients. Our results call attention to its potential risks of both acute and chronic kidney failure.

Keyphrases

chronic kidney disease
end stage renal disease
ejection fraction
newly diagnosed
drug induced
prognostic factors
working memory
respiratory failure
risk assessment
climate change